乐观
$61.55
情景价格
$72.210
+2.260 (+3.13%)收盘时
Utah Medical Products, Inc. manufactures and markets a range of specialty medical devices. The Company’s range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians offices. Its products are sold directly to end-user facilities in the United States, Ireland, United Kingdom, Canada, France and Australia, and through third party distributors in other outside the United States (OUS) markets. It offers fetal monitoring accessories. Its specialized labour and delivery tools include BT-Cath, CVX-Ripe, AROM-COT, MUC-X, and Cordguard. The Company’s vacuum-assisted delivery (VAD) systems include CMI soft silicone bell-shaped birthing cups and reusable hand-held vacuum pumps, which are the safest products available for use in vacuum-assisted operative deliveries. Its neonatal intensive care products include Disposa-Hood and GESCO. It also distributes harm-reduction medical devices.
Utah Medical Products is currently a hold. The stock is trading at $70.55, which is 72.7% of its 52-week range, indicating it is closer to its high than its low. The forward P/E ratio is 13.04, suggesting it is reasonably valued compared to its earnings potential. However, the RSI is at 44.47, indicating it is not yet oversold, and the recent 5-day change of -4.04% shows a downward trend that may continue in the short term.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Latest Stock Updates from Analyst Blog

Utah Medical Products Q1 Financial Results

Analyst Blog Stock Updates from Zacks

Utah Medical Products Reports Q4 Earnings

UTMD Reports Year-over-Year Decline in Q3 Earnings Due to Trade Disruptions and Margin Pressures
Utah Medical Products, Inc. manufactures and markets a range of specialty medical devices. The Company’s range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians offices. Its products are sold directly to end-user facilities in the United States, Ireland, United Kingdom, Canada, France and Australia, and through third party distributors in other outside the United States (OUS) markets. It offers fetal monitoring accessories. Its specialized labour and delivery tools include BT-Cath, CVX-Ripe, AROM-COT, MUC-X, and Cordguard. The Company’s vacuum-assisted delivery (VAD) systems include CMI soft silicone bell-shaped birthing cups and reusable hand-held vacuum pumps, which are the safest products available for use in vacuum-assisted operative deliveries. Its neonatal intensive care products include Disposa-Hood and GESCO. It also distributes harm-reduction medical devices. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
Utah Medical Products is currently a hold. The stock is trading at $70.55, which is 72.7% of its 52-week range, indicating it is closer to its high than its low. The forward P/E ratio is 13.04, suggesting it is reasonably valued compared to its earnings potential. However, the RSI is at 44.47, indicating it is not yet oversold, and the recent 5-day change of -4.04% shows a downward trend that may continue in the short term.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。